First-in-Human Experience With Peritoneal Direct Sodium Removal Using a Zero-Sodium Solution
Veena S. Rao(Yale University), Jeffrey M. Testani(Yale University), Jennifer L. Asher(Yale University), Jeffrey M. Turner(Yale University), Attila Fehér(Yale University), F. Perry Wilson(Yale University), Albert J. Sinusas(Yale University), Nabil E. Boutagy(Center for Vascular Biology Research), Devin Mahoney(Yale University), Fredric O. Finkelstein, Sangchoon Jeon(Yale University), Matthew D. Griffin(Ollscoil na Gaillimhe – University of Galway), Peter S. Yoo(Yale University)
Cited by 35
Related Papers
Metabolic endotoxemia with obesity: Is it real and is it relevant?
|Biochimie|2015|392
Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
|Kidney International|2018|244
Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States
|American Journal of Kidney Diseases|2020|234
Rationale and design of the Kidney Precision Medicine Project
|Kidney International|2021|187